BIO-XCELL TO SHOWCASE MALAYSIA'S BIO STRENGTH IN US

Malaysian Bio-XCell Sdn Bhd (Bio-XCell),
the investment arm of Malaysian Biotechnology Corporation (BiotechCorp), will
showcase Malaysia's biotechnology ecosystem and the country's strength as a
regional biotech hub at the Bio International Convention 2011 (BIO DC 2011)
here.

The three-day annual convention, dubbed the biggest in the world, will be
held at Walter E. Washington Convention Centre beginning Tuesday.

Deputy Prime Minister Muhyiddin Yassin, who arrived here on Monday,
is leading the Malaysian delegation to the event.

And, for the first time in the history of the event, Muhyiddin will be
the first foreign leader given the honour to officiate the BIO international
convention alongside Maryland Governor Martin O'Malley and BIO President and
Chief Executive Officer James Greenwood.

The BIO DC 2011, expected to draw over 15,000 industry leaders from
over 60 countries, is being organised by BIO, the world's largest biotechnology
organisation based in the US providing advocacy, business development and
communication services to over 1,100 members, worldwide.

Bio-XCell, which is participating for the second time in the BIO conference,
will showcase Malaysia's biotechnology ecosystem and the country's strength as a
regional biotech hub, says its Chief Executive Officer Raja Ridzwa Raja
Abdul Aziz.

Speaking to Malaysian journalists who are here to cover the BIO DC 2011,
Raja Ridzwa said the company has entered its commercial phase as it was ready to
accept foreign biotechnology companies interested to set up manufacturing
facilities at its custom-built biotechnology park and ecosystem in Iskandar
Malaysia.

Bio-Xcell is a dedicated biotechnology hub, catering to the bioprocessing
and biomanufacturing needs of global and regional players, and a strategic tool
to carry out the commercialisation strategy of BiotechCorp in bringing
innovations from laboratories to market.

The company is spending about RM950 million to get the park ready by next
year with all the facilities needed to accommodate the foreign biopharma and bio
industrial investors.

Raja Ridzwa said Muhyiddin would witness the signing of two agreements, one
with a major player that would support the development of Bio-Xcell and another
with an Asian-based company that has tremendous presence in the US, hence
marking yet another significant step towards enhancing the infrastructure of the
ecosystem and also the hub's tenant mix.

BiotechCorp will also see a couple of memoranda of collaboration signed
between Malaysian biotech companies and global counterparts from Russia and
Norway, enhancing Malaysia's edge in the space of industrial biotechnology.

Meanwhile, BiotechCorp Chief Operations Officer Dr Wan Abdul Rahaman Wan
Yaacob said the corporation would also be taking a big step by co-hosting the
annual 2011 BioMalaysia with the 2011 Bio Pacific Rim Summit on Industrial
Biotechnology and Bioenergy.

He said for the very first time, the 2011 Pacific Rim Summit in
Industrial Biotechnology and Bioenergy would be held outside the US and would
place Malaysia on the global map of industrial biotechnology and highlight
Malaysia's competitive advantage in industrial bio-processing and
bio-manufacturing.

Raja Ridzwa said since its launch internationally last year at the BIO
Chicago 2010, Bio-XCell had secured investments worth more than US$200 million
for its biotechnology park in Iskandar Malaysia.

The three global industry leaders are Biocon of India, Metabolic Explorer of
France and Glycos Biotechnologies of the United States.

He added the return on investment on the biotechnology park, would begin
from 2013 onwards and the entire investment was expected to be recouped in eight
to 10 years.